Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Change In Receivables : $66.8 Mil (TTM As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

What is Taro Pharmaceutical Industries Change In Receivables?

Taro Pharmaceutical Industries's change in receivables for the quarter that ended in Dec. 2023 was $-2.6 Mil. It means Taro Pharmaceutical Industries's Accounts Receivable increased by $2.6 Mil from Sep. 2023 to Dec. 2023 .

Taro Pharmaceutical Industries's change in receivables for the fiscal year that ended in Mar. 2023 was $39.7 Mil. It means Taro Pharmaceutical Industries's Accounts Receivable declined by $39.7 Mil from Mar. 2022 to Mar. 2023 .

Taro Pharmaceutical Industries's Accounts Receivable for the quarter that ended in Dec. 2023 was $191.2 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Taro Pharmaceutical Industries's Days Sales Outstanding for the three months ended in Dec. 2023 was 111.04.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Taro Pharmaceutical Industries's liquidation value for the three months ended in Dec. 2023 was $769.0 Mil.

Taro Pharmaceutical Industries Change In Receivables Historical Data

The historical data trend for Taro Pharmaceutical Industries's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Change In Receivables Chart

Taro Pharmaceutical Industries Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Receivables

Get a 7-Day Free Trial

42.17

14.86

5.36

-11.68

39.72

Taro Pharmaceutical Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-1.55	37.60	-24.31	56.10	-2.64

Taro Pharmaceutical Industries Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $66.8 Mil.

Taro Pharmaceutical Industries (NYSE:TARO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Taro Pharmaceutical Industries's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	191.232	/	157.145	*	91
=	111.04

2. In Ben Graham's calculation of liquidation value, Taro Pharmaceutical Industries's accounts receivable are only considered to be worth 75% of book value:

Taro Pharmaceutical Industries's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	902.216	-	384.086	+	0.75 * 191.232	+	0.5 * 214.816
=	769.0

Taro Pharmaceutical Industries Change In Receivables Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (NYSE:TARO) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

TAL:Germany

Address

14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761

Website

https://www.taro.com

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Executives

Sun Pharma Global Inc	10 percent owner
Sun Pharmaceutical Industries Ltd	10 percent owner, other: Affiliated Party	17/B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDEHERI (EAST) K7 400 093
Alkaloida Chemical Co Exclusive Group Ltd.	10 percent owner	KABAY JANOS UT 29., TISZAVASVARI K5 4440
Franklin Resources Inc	10 percent owner	FRANKLIN RESOURCES INC, ONE FRANKLIN PARKWAY, SAN MATEO CA 94403